Supplemental material
Open access
301
Views
0
CrossRef citations to date
0
Altmetric
Rare Diseases
Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey
Jon Vlasnika Alexion Pharmaceuticals Inc, AstraZeneca Rare Disease, Boston, MA, USAView further author information
, M. Janelle Cambron-Mellottb Oracle Corporation, Oracle Life Sciences, Austin, TX, USAhttps://orcid.org/0000-0003-0061-104XView further author information
, Halley Costantinob Oracle Corporation, Oracle Life Sciences, Austin, TX, USAhttps://orcid.org/0009-0000-6658-6057View further author information
& Mary Kunjappua Alexion Pharmaceuticals Inc, AstraZeneca Rare Disease, Boston, MA, USACorrespondence[email protected]
https://orcid.org/0009-0004-3374-9437View further author information
https://orcid.org/0009-0004-3374-9437View further author information
Pages 863-876
|
Received 05 Dec 2023, Accepted 28 Mar 2024, Published online: 14 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.